Molecular docking study of L-Asparaginase I from Vibrio campbellii in the treatment of acute lymphoblastic leukemia (ALL)

1Michalska K, Bujacz G, Jaskolski M. Crystal structure of plant asparaginase. J Mol Biol. 2006; 360: 105-116.MichalskaKBujaczGJaskolskiMCrystal structure of plant asparaginaseJ Mol Biol200636010511610.1016/j.jmb.2006.04.066Search in Google Scholar

2Deb AC. Fundamentals of Biochemistry. New Central Book Agency (P) Ltd. India; 1994.DebACFundamentals of BiochemistryNew Central Book Agency (P) LtdIndia1994Search in Google Scholar

3National Cancer Institute. NCI Dictionary of Cancer terms. Bethesda MD. 18.03d. 2018. https://www.cancer.gov/publications/dictionaries/cancer-terms Accessed on 20 Jan 2019.National Cancer Institute. NCI Dictionary of Cancer terms. Bethesda MD. 18.03d2018https://www.cancer.gov/publications/dictionaries/cancer-termsAccessed on 20 Jan 2019Search in Google Scholar

4Konevalova NYu, Buyanova SV. Biochemistry Lecture Course. Ministry of Health of Republic of Belarus Vitebsk State Medical Universite. Vitebsk; 2013. p.163.KonevalovaNYuBuyanovaSVBiochemistry Lecture CourseMinistry of Health of Republic of Belarus Vitebsk State Medical UniversiteVitebsk2013163Search in Google Scholar

5Peterson RE, Ciegler A . L-asparaginase production by various bacteria. Applied Microbiology. 1969; 17(6):929- 930.PetersonRECieglerAL-asparaginase production by various bacteriaApplied Microbiology196917692993010.1128/am.17.6.929-930.1969Search in Google Scholar

6DeJong PJ. L-asparaginase production by Streptomyces griseus. Applied & Environmental Microbiology. 1972; 23 (6):1163-1164.DeJongPJ.L-asparaginase production by Streptomyces griseusApplied & Environmental Microbiology19722361163116410.1128/am.23.6.1163-1164.1972Search in Google Scholar

7Kafkewitz D, Goodman D. L-asparaginase Production by the Rumen Anaerobe Vibrio succinogenes. Applied & Environmental Microbiology. 1974; 27(1): 206-209.KafkewitzDGoodmanDL-asparaginase Production by the Rumen Anaerobe Vibrio succinogenesApplied & Environmental Microbiology197427120620910.1128/am.27.1.206-209.1974Search in Google Scholar

8Sarquis MIdeMoura, Oliveira EMM, Santos AS, da Costa GL. Production of L-asparaginase by filamentous fungi. Memórias do Instituto Oswaldo Cruz. 2004; 99(5): 489-492.SarquisMIdeMouraOliveiraEMMSantosASda CostaGLProduction of L-asparaginase by filamentous fungiMemórias do Instituto Oswaldo Cruz200499548949210.1590/S0074-02762004000500005Search in Google Scholar

9Cornea CP, Lupescu I, Vatafu I, Caraiani T, Savoiu VG, Campeanu Gh, Grebenisan I, Negulescu Gh.P, Constantinescu D. Production of L-asparaginase II by Recombinant Escherichia coli cells. Roumanian Biotechnology Letters. 2002; 7(3):717-722.CorneaCPLupescuIVatafuICaraianiTSavoiuVGCampeanuGhGrebenisanINegulescuGh.PConstantinescuDProduction of L-asparaginase II by Recombinant Escherichia coli cellsRoumanian Biotechnology Letters200273717722Search in Google Scholar

10Mashburn LT, Wriston JC. Tumor inhibitory effect of L asparaginase from Escherichia coli. Arch Biochem Biophys. 1964; 105:450–453.MashburnLTWristonJCTumor inhibitory effect of L asparaginase from Escherichia coliArch Biochem Biophys196410545045310.1016/0003-9861(64)90032-3Search in Google Scholar

11Pieters R, Carroll WL. Biology and treatment of acute lymphoblastic leukemia. Pediatr Clin North Am. 2008; 55(1):1-20.[PubMed]PietersRCarrollWLBiology and treatment of acute lymphoblastic leukemiaPediatr Clin North Am2008551120PubMed10.1016/j.pcl.2007.11.00218242313Search in Google Scholar

12Goekbuget N, Baumann A, Beck J, Boos J, Brueggemann M, Diedrich H. PEG-asparaginase in adult acute lymphoblastic leukemia (ALL): efficacy and feasibility analysis with increasing dose levels. Blood. 2008; 112.GoekbugetNBaumannABeckJBoosJBrueggemannMDiedrichHPEG-asparaginase in adult acute lymphoblastic leukemia (ALL): efficacy and feasibility analysis with increasing dose levelsBlood200811210.1182/blood.V112.11.302.302Search in Google Scholar

13Savitri, Asthana N, Azmi W. Microbial L-Asparaginase: A potent antitumor enzyme. Indian Journal of Biotechnology. 2003; 2:184-194.SavitriAsthana NAzmiWMicrobial L-Asparaginase: A potent antitumor enzymeIndian Journal of Biotechnology20032184194Search in Google Scholar

14Swain AL, Jaskolski M, Housset D, Rao JK, Wlodawer A. Crystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapy. Proc Natl Acad Sci USA. 1993a; 90(4):pp.1474.SwainALJaskolskiMHoussetDRaoJKWlodawerACrystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapyProc Natl Acad Sci USA1993a904147410.1073/pnas.90.4.1474458968434007Search in Google Scholar

15Dhevagi P, Poorani E . Isolation and characterization of L-Asparaginase from marine Actinomycetes. Indian Journal of Biotechnology. 2006; 5:514-520.DhevagiPPooraniEIsolation and characterization of L-Asparaginase from marine ActinomycetesIndian Journal of Biotechnology20065514520Search in Google Scholar

16Capizzi RL, Bertino JR and Skeel RT. L-asparaginase: Clinical, biochemical, pharmacological, and immunological studies. Ann Intern Med. 1971; 74: 893-901.CapizziRLBertinoJRSkeelRT.L-asparaginase: Clinical, biochemical, pharmacological, and immunological studiesAnn Intern Med19717489390110.7326/0003-4819-74-6-8935281051Search in Google Scholar

17Davis BD, Mingioli ES. Mutants of Escherichia coli requiring methionine or vitamin B12. Journal of Bacteriology. 1950; 60(1):17-28.DavisBDMingioliESMutants of Escherichia coli requiring methionine or vitamin B12Journal of Bacteriology1950601172810.1128/jb.60.1.17-28.195038583615436457Search in Google Scholar

18Gallagher MP, Marshall RD, Wilson R. Asparaginase as a drug for treatment of acute lymphoblastic leukaemia. Essays Biochemistry. 1989; 24: 1-40.GallagherMPMarshallRDWilsonRAsparaginase as a drug for treatment of acute lymphoblastic leukaemiaEssays Biochemistry198924140Search in Google Scholar

19Lubkowski J, Dauter M, Aghaiypour K, Wlodawer A, Dauter Z. Atomic Resolution Structure of Erwinia chrysanthemi L-Asparaginase Acta Crystlography D. 2003; 59: 84–92.LubkowskiJDauterMAghaiypourKWlodawerADauterZAtomic Resolution Structure of Erwinia chrysanthemi L-Asparaginase Acta Crystlography D200359849210.1107/S090744490201944312499544Search in Google Scholar

20Dimitrov I, Bangov I, Flower DR, Doytchinova I. AllerTOP v.2. A server for in silico prediction of allergens. J Mol Model. 2014; doi: 10.1007/s00894-014-2278-5. [Epub].DimitrovIBangovIFlowerDRDoytchinovaIAllerTOP v.2. A server for in silico prediction of allergensJ Mol Model201410.1007/s00894-014-2278-5Epub24878803Open DOISearch in Google Scholar

21Geourjon C, Deleage G. SOPMA: Significant Improvements in Protein Secondary Structure Prediction by Consensus Prediction from Multiple Alignments. Comput Appl Biosci. 1995; 11: 681–684.GeourjonCDeleageGSOPMA: Significant Improvements in Protein Secondary Structure Prediction by Consensus Prediction from Multiple AlignmentsComput Appl Biosci19951168168410.1093/bioinformatics/11.6.6818808585Search in Google Scholar

22Kuntal BK, Aparoy P, Reddanna P . EasyModeller: A graphical interface to MODELLER. BMC Res Notes. 2010; doi: 10.1186/1756-0500-3-226.KuntalBKAparoyPReddannaPEasyModeller: A graphical interface to MODELLERBMC Res Notes201010.1186/1756-0500-3-226293691220712861Open DOISearch in Google Scholar

23Lovell S C, Davis I W, Arendall III W B, de Bakker P I W, Word JM, Prisant M G, Richardson JS, Richardson D C. . Structure validation by Calpha geometry: phi,psi and Cbeta deviation. Proteins: Structure, Function & Genetics. 2003; 50: 437-450.LovellS CDavisI WArendallIII W Bde BakkerP I WWordJMPrisantM GRichardsonJSRichardsonDCStructure validation by Calpha geometry: phi,psi and Cbeta deviationProteins: Structure, Function & Genetics20035043745010.1002/prot.1028612557186Search in Google Scholar

24Wallner B., Elofsson A 2003. Protein structure prediction and model quality assessment. Protein Sci. 2003; 112: 1073-1086.WallnerB.ElofssonA2003Protein structure prediction and model quality assessmentProtein Sci20031121073108610.1110/ps.0236803232387712717029Search in Google Scholar

25Shin W H, Lee G R, Heo L, Lee H, Seok C . Prediction of Protein Structure and Interaction by GALAXY protein modeling programs. Bio Design. 2014; 2 (1): 1-11.ShinW HLeeG RHeoLLeeHSeokCPrediction of Protein Structure and Interaction by GALAXY protein modeling programsBio Design201421111Search in Google Scholar

26Thompson M A. Molecular docking using ArgusLab, an efficient shape-based search algorithm and the AScore scoring function. ACS meeting, Philadelphia, 172, CINF 42, PA. 2004.ThompsonM AMolecular docking using ArgusLab, an efficient shape-based search algorithm and the AScore scoring functionACS meetingPhiladelphia172, CINF 42, PA2004Search in Google Scholar

27Wallace, A. C., Laskowski, R. A, Thornton, J. M. LIGPLOT-A program to generate schematic diagrams of protein ligand interactions. Prot. Eng. 1995; 8: 127–134.WallaceA. C.LaskowskiR. AThorntonJ. MLIGPLOT-A program to generate schematic diagrams of protein ligand interactionsProt. Eng1995812713410.1093/protein/8.2.1277630882Search in Google Scholar

28Schneidman-Duhovny D, Inbar Y, Nussinov R, Wolfson H). Nucl Acids Res. 2005 33(Web Server issue):W363–W367.Schneidman-DuhovnyDInbarYNussinovRWolfsonHNucl Acids Res200533Web Server issueW363W36710.1093/nar/gki481116024115980490Search in Google Scholar

29Nocek B, Wu R, Osipiuk J, Moy S, Kim Y, Joachimiak A. Crystal structure of L-asparaginase I from Vibrio cholerae O1 Biovar eltor str. N16961.Midwest Center for Structural Genomics (MCSG). 2006; doi: 10.2210/pdb2OCD/pdb.NocekBWuROsipiukJMoySKimYJoachimiakACrystal structure of L-asparaginase I from Vibrio cholerae O1 Biovar eltor strN16961.Midwest Center for Structural Genomics (MCSG)200610.2210/pdb2OCD/pdbOpen DOISearch in Google Scholar

30Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, Bairoch A. Protein identification and analysis tools on the ExPASy server. In: Walker JM, editor. The Proteomics Protocols Handbook. Clifton, UK: Humana Press. 2005.GasteigerEHooglandCGattikerADuvaudSWilkinsMRAppelRDBairochAProtein identification and analysis tools on the ExPASy serverWalkerJMeditorThe Proteomics Protocols HandbookClifton, UKHumana Press200510.1385/1-59259-890-0:571Search in Google Scholar

31Chen SH, Yang CY, Chen PF, Setzer D, Tanimura M, Li WH, Gotto AM Jr, Chan L. The complete cDNA and amino acid sequence of human apolipoprotein B-100. J Biol Chem. 1986; 261:12918-12921.ChenSHYangCYChenPFSetzerDTanimuraMLiWHGottoAM JrChanLThe complete cDNA and amino acid sequence of human apolipoprotein B-100J Biol Chem1986261129181292110.1016/S0021-9258(18)69248-8Search in Google Scholar

32Kwon YM, Chung HS, Moon C, Yockman J, Park YJ, Gitlin SD. LAsparaginase encapsulated intact erythrocytes for treatment of acute lymphoblastic leukemia (ALL). J Control Release. 2009; 139 (3):182–9.KwonYMChungHSMoonCYockmanJParkYJGitlinSDLAsparaginase encapsulated intact erythrocytes for treatment of acute lymphoblastic leukemia (ALL)J Control Release20091393182910.1016/j.jconrel.2009.06.027Search in Google Scholar

33National Cancer Institute. NCI Dictionary of Cancer terms. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/peg-asparaginase Accessed on 01 Sep 2019.National Cancer Institute. NCI Dictionary of Cancer termshttps://www.cancer.gov/publications/dictionaries/cancer-terms/def/peg-asparaginaseAccessed on 01 Sep2019Search in Google Scholar

34Yun MK, Nourse A, White SW, Rock CO, Heath RJ. Crystal structure and allosteric regulation of the cytoplasmic Escherichia coli L-asparaginase I. J Mol Biol. 2007; doi:10.1016/j.jmb.2007.03.061.YunMKNourseAWhiteSWRockCOHeathRJCrystal structure and allosteric regulation of the cytoplasmic Escherichia coli L-asparaginase IJ Mol Biol200710.1016/j.jmb.2007.03.061Open DOISearch in Google Scholar

35Watenpaugh K D, Sieker L C, Jensen L H. Proc Natl Acad Sci USA. 1973; 70: 3857-3860.WatenpaughK DSiekerL CJensenL HProc Natl Acad Sci USA1973703857386010.1073/pnas.70.12.3857Search in Google Scholar

36Swain AL, Jaskolski M, Housset D, Rao JK, Wlodawer A. Crystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapy. Proc Natl Acad Sci USA. 1993b; 90(4): p. 1477.SwainALJaskolskiMHoussetDRaoJKWlodawerACrystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapyProc Natl Acad Sci USA1993b904147710.1073/pnas.90.4.1474Search in Google Scholar

37Berg JM, Tymoczko JL, Stryer L. Biochemistry, 7th revised International Edition. W.H. Freeman & Company. 2012.BergJMTymoczkoJLStryerLBiochemistry, 7th revised International EditionW.H. Freeman & Company201210.1007/978-3-8274-2989-6Search in Google Scholar

38Swain AL, Jaskolski M, Housset D, Rao JK, Wlodawer A. Crystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapy. Proc Natl Acad Sci USA. 1993c; 90(4): p.1477.SwainALJaskolskiMHoussetDRaoJKWlodawerACrystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapyProc Natl Acad Sci USA1993c904147710.1073/pnas.90.4.1474Search in Google Scholar

39Reddy ER, Babu RS, Chandrasai PD, Madhuri P. Exploration of the binding modes of l-asparaginase complexed with its amino acid substrates by molecular docking, dynamics and simulation. 3. Biotech. 2016; 6:105.ReddyERBabuRSChandrasaiPDMadhuriPExploration of the binding modes of l-asparaginase complexed with its amino acid substrates by molecular docking, dynamics and simulation3. Biotech2016610510.1007/s13205-016-0422-xSearch in Google Scholar

40Stryer L, Berg JM, Tymoczko JL. “9 Catalytic Strategies”. Biochemistry, 5th edition: San Francisco: W.H. Freeman. 2002. https://en.wikipedia.org/wiki/Catalytic_triad?oldid=745555039Accessed 20 Jan 2019.StryerLBergJMTymoczkoJL“9 Catalytic Strategies”Biochemistry5th editionSan FranciscoW.H. Freeman2002https://en.wikipedia.org/wiki/Catalytic_triad?oldid=745555039Accessed 20 Jan 2019Search in Google Scholar

41Sanches M, Krauchenco S, Polikarpov I. Structure, Substrate Complexation and Reaction Mechanism of Bacterial Asparaginases. Curr Chem Biol. 2007; 12: 75–86.SanchesMKrauchencoSPolikarpovIStructure, Substrate Complexation and Reaction Mechanism of Bacterial AsparaginasesCurr Chem Biol200712758610.2174/2212796810701010075Search in Google Scholar

42Palm G, Lubkowski J, Derst C, Schleper S, Roehm KH, Wlodawer A. A covalently bound catalytic intermediate in Escherichia coli asparaginase: Crystal structure of a Thr-89-Val mutant. FEBS Lett. 1996; 390: 211-216.PalmGLubkowskiJDerstCSchleperSRoehmKHWlodawerAA covalently bound catalytic intermediate in Escherichia coli asparaginase: Crystal structure of a Thr-89-Val mutantFEBS Lett199639021121610.1016/0014-5793(96)00660-6Search in Google Scholar

43Swain AL, Jaskolski M, Housset D, Rao JK, Wlodawer A. Crystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapy. Proc Natl Acad Sci USA. 1993d; 90(4):p. 1474.SwainALJaskolskiMHoussetDRaoJKWlodawerACrystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapyProc Natl Acad Sci USA1993d904147410.1073/pnas.90.4.1474458968434007Search in Google Scholar

44Derst C, Henseling J, Ro¨hm KH. Engineering the substrate specificity of Escherichia coli asparaginase II. Selective reduction of glutaminase activity by amino acid replacements at position 248. Protein Sci. 2000; 9:2009–2017.DerstCHenselingJRo¨hmKHEngineering the substrate specificity of Escherichia coli asparaginase II. Selective reduction of glutaminase activity by amino acid replacements at position 248Protein Sci200092009201710.1110/ps.9.10.2009214445311106175Search in Google Scholar